TransThera Sciences (Nanjing), Inc. (HKG:2617)
Hong Kong
· Delayed Price · Currency is HKD 82.05
-3.50 (-4.09%)
Mar 10, 2026, 11:15 AM HKT
HKG:2617 Market Cap
HKG:2617 has a market cap or net worth of 34.13 billion as of March 9, 2026.
Market Cap
34.13B
Enterprise Value
33.44B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
82.05
Market Cap Chart
Since June 23, 2025, HKG:2617's market cap has increased from 9.33B to 34.13B, an increase of 265.97%. That is a compound annual growth rate of 535.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 36.71B | -19.51% |
| Dec 31, 2025 | 45.60B | 388.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 35.28B |
| Shanghai Henlius Biotech | 35.84B |
| Shanghai Junshi Biosciences | 31.56B |
| Duality Biotherapeutics | 28.21B |
| Genscript Biotech | 25.54B |
| InnoCare Pharma | 23.64B |
| 3SBio | 51.05B |
| PegBio | 21.51B |